483 Response Lacrimedics Jan 2020

Christopher Czajka FDA, Stephen Souza FDA$119.00 - Available Now

FDA investigators audited the Lacrimedics - DuPont, WA, United States facility and issued inspectional observation (via FDA 483) on 23 Jan 2020.

Product details

  • Category:
  • Inspection end: 23 Jan 2020
  • Location: DuPont, United States
  • FEI: 2024818
Add To Cart